FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200239904> ?p ?o ?g. }

• W4200239904 endingPage "1705" @default.
• W4200239904 startingPage "1700" @default.
• W4200239904 abstract "The mRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech) provide strong protection against severe COVID-19, including hospitalization, for at least several months after receipt of the second dose (1,2). However, studies examining immune responses and differences in protection against COVID-19-associated hospitalization in real-world settings, including by vaccine product, are limited. To understand how vaccine effectiveness (VE) might change with time, CDC and collaborators assessed the comparative effectiveness of Moderna and Pfizer-BioNTech vaccines in preventing COVID-19-associated hospitalization at two periods (14-119 days and ≥120 days) after receipt of the second vaccine dose among 1,896 U.S. veterans at five Veterans Affairs medical centers (VAMCs) during February 1-September 30, 2021. Among 234 U.S. veterans fully vaccinated with an mRNA COVID-19 vaccine and without evidence of current or prior SARS-CoV-2 infection, serum antibody levels (anti-spike immunoglobulin G [IgG] and anti-receptor binding domain [RBD] IgG) to SARS-CoV-2 were also compared. Adjusted VE 14-119 days following second Moderna vaccine dose was 89.6% (95% CI = 80.1%-94.5%) and after the second Pfizer-BioNTech dose was 86.0% (95% CI = 77.6%-91.3%); at ≥120 days VE was 86.1% (95% CI = 77.7%-91.3%) for Moderna and 75.1% (95% CI = 64.6%-82.4%) for Pfizer-BioNTech. Antibody levels were significantly higher among Moderna recipients than Pfizer-BioNTech recipients across all age groups and periods since vaccination; however, antibody levels among recipients of both products declined between 14-119 days and ≥120 days. These findings from a cohort of older, hospitalized veterans with high prevalences of underlying conditions suggest the importance of booster doses to help maintain long-term protection against severe COVID-19.†." @default.
• W4200239904 created "2021-12-31" @default.
• W4200239904 creator A5001926822 @default.
• W4200239904 creator A5003981348 @default.
• W4200239904 creator A5005794809 @default.
• W4200239904 creator A5007455793 @default.
• W4200239904 creator A5008225213 @default.
• W4200239904 creator A5009538084 @default.
• W4200239904 creator A5010409081 @default.
• W4200239904 creator A5010601374 @default.
• W4200239904 creator A5010693277 @default.
• W4200239904 creator A5012988060 @default.
• W4200239904 creator A5013038413 @default.
• W4200239904 creator A5013472166 @default.
• W4200239904 creator A5015599883 @default.
• W4200239904 creator A5016323896 @default.
• W4200239904 creator A5020261373 @default.
• W4200239904 creator A5021881212 @default.
• W4200239904 creator A5021995294 @default.
• W4200239904 creator A5022396107 @default.
• W4200239904 creator A5022882130 @default.
• W4200239904 creator A5026518567 @default.
• W4200239904 creator A5028609449 @default.
• W4200239904 creator A5030761539 @default.
• W4200239904 creator A5035273187 @default.
• W4200239904 creator A5037742092 @default.
• W4200239904 creator A5037920959 @default.
• W4200239904 creator A5038499417 @default.
• W4200239904 creator A5040516538 @default.
• W4200239904 creator A5041342651 @default.
• W4200239904 creator A5043385609 @default.
• W4200239904 creator A5045467984 @default.
• W4200239904 creator A5047057572 @default.
• W4200239904 creator A5048385331 @default.
• W4200239904 creator A5051187579 @default.
• W4200239904 creator A5051651608 @default.
• W4200239904 creator A5051791249 @default.
• W4200239904 creator A5052536508 @default.
• W4200239904 creator A5053367962 @default.
• W4200239904 creator A5054461573 @default.
• W4200239904 creator A5054547961 @default.
• W4200239904 creator A5055100220 @default.
• W4200239904 creator A5055603602 @default.
• W4200239904 creator A5055817742 @default.
• W4200239904 creator A5057035673 @default.
• W4200239904 creator A5059568970 @default.
• W4200239904 creator A5060513146 @default.
• W4200239904 creator A5061800469 @default.
• W4200239904 creator A5063377754 @default.
• W4200239904 creator A5063495010 @default.
• W4200239904 creator A5063721437 @default.
• W4200239904 creator A5066869339 @default.
• W4200239904 creator A5067206736 @default.
• W4200239904 creator A5067515532 @default.
• W4200239904 creator A5067685734 @default.
• W4200239904 creator A5068444424 @default.
• W4200239904 creator A5068844252 @default.
• W4200239904 creator A5069439174 @default.
• W4200239904 creator A5074007576 @default.
• W4200239904 creator A5075575064 @default.
• W4200239904 creator A5075587520 @default.
• W4200239904 creator A5075720122 @default.
• W4200239904 creator A5078558068 @default.
• W4200239904 creator A5083018436 @default.
• W4200239904 creator A5084682471 @default.
• W4200239904 creator A5087653992 @default.
• W4200239904 creator A5090168506 @default.
• W4200239904 creator A5090575142 @default.
• W4200239904 creator A5090722204 @default.
• W4200239904 creator A5090927606 @default.
• W4200239904 creator A5069508176 @default.
• W4200239904 creator A9999999999 @default.
• W4200239904 date "2021-12-10" @default.
• W4200239904 modified "2023-10-01" @default.
• W4200239904 title "Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021" @default.
• W4200239904 cites W2010123683 @default.
• W4200239904 cites W3142193311 @default.
• W4200239904 cites W3163785571 @default.
• W4200239904 cites W3195990721 @default.
• W4200239904 cites W3196397911 @default.
• W4200239904 cites W3199384045 @default.
• W4200239904 cites W3200060278 @default.
• W4200239904 cites W3208997625 @default.
• W4200239904 doi "https://doi.org/10.15585/mmwr.mm7049a2" @default.
• W4200239904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34882654" @default.
• W4200239904 hasPublicationYear "2021" @default.
• W4200239904 type Work @default.
• W4200239904 citedByCount "64" @default.
• W4200239904 countsByYear W42002399042021 @default.
• W4200239904 countsByYear W42002399042022 @default.
• W4200239904 countsByYear W42002399042023 @default.
• W4200239904 crossrefType "journal-article" @default.
• W4200239904 hasAuthorship W4200239904A5001926822 @default.
• W4200239904 hasAuthorship W4200239904A5003981348 @default.
• W4200239904 hasAuthorship W4200239904A5005794809 @default.
• W4200239904 hasAuthorship W4200239904A5007455793 @default.
• W4200239904 hasAuthorship W4200239904A5008225213 @default.
• W4200239904 hasAuthorship W4200239904A5009538084 @default.

• next